Search by Drug Name or NDC
NDC 50268-0568-15 Mupirocin 20 mg/g Details
Mupirocin 20 mg/g
Mupirocin is a TOPICAL OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is MUPIROCIN.
MedlinePlus Drug Summary
Mupirocin, an antibiotic, is used to treat impetigo as well as other skin infections caused by bacteria. It is not effective against fungal or viral infections. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 50268-0568-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mupirocin
Product Information
| NDC | 50268-0568 |
|---|---|
| Product ID | 50268-568_0e773c6a-0175-fae5-e063-6294a90af595 |
| Associated GPIs | 90100065104210 |
| GCN Sequence Number | 007732 |
| GCN Sequence Number Description | mupirocin OINT. (G) 2 % TOPICAL |
| HIC3 | Q5W |
| HIC3 Description | TOPICAL ANTIBIOTICS |
| GCN | 47450 |
| HICL Sequence Number | 003385 |
| HICL Sequence Number Description | MUPIROCIN |
| Brand/Generic | Generic |
| Proprietary Name | Mupirocin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Mupirocin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/g |
| Substance Name | MUPIROCIN |
| Labeler Name | AvPAK |
| Pharmaceutical Class | RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065170 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 50268-0568-15 (50268056815)
| NDC Package Code | 50268-568-15 |
|---|---|
| Billing NDC | 50268056815 |
| Package | 50 TUBE in 1 BOX (50268-568-15) / 50 g in 1 TUBE (50268-568-11) |
| Marketing Start Date | 2019-06-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |